Patient Satisfaction After Switching to Oral Testosterone Undecanoate

NCT04983940 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Testosterone Deficiency

Interventions

DRUG: Jatenzo

Sponsor

University of Miami

Collaborators

[object Object]